FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
31 letters match. Newest first.
-
DrugsUSV Private Limited
FDA warned USV Private Limited that its sterile injectable manufacturing in Daman, India, had aseptic-processing, facility-design and visible-particulate violations.
High risk -
DevicesPro-Optics, LLC
FDA warned Pro-Optics about unapproved material and color changes to contact lens cases and quality system failures.
Medium -
DevicesChirp Innovations, LLC
FDA warned Chirp Innovations over quality-system gaps, missing adverse-event reporting procedures, and unapproved marketing of its Halo muscle stimulator for menstrual pain.
High risk -
DevicesPeter Schiff Enterprises
FDA warns Peter Schiff Enterprises over unapproved cardiac devices and serious quality system failures.
High risk -
DrugsRohto Pharmaceutical Co., Ltd.
FDA cites Rohto Vietnam eye-drop plant for falsified sterility records, poor aseptic practices, and unapproved Cooling Eye Drops.
High risk -
DevicesOlympus Medical Systems Corporation
FDA warns Olympus over quality-system failures across six medical device plants, including unvalidated designs and released nonconforming devices.
High risk -
DrugsSignature Formulations LLC
FDA warns Signature Formulations about contaminated contract-manufactured drug products and cross-contamination at its Phoenix facility.
High risk -
DevicesUnilam Co., LTD
Unilam Co., LTD's UV sunlamps violate quality-system and radiation-safety testing rules, FDA says.
High risk -
DevicesSpecialty Health Products CO, LLC
Specialty Health Products was cited for quality-system, unapproved marketing, and listing violations for its Hydro-San and Aqua Cleanse colonic irrigation devices.
High risk -
DrugsBausch & Lomb Inc.
FDA warns Bausch & Lomb of persistent microbial contamination and poor aseptic controls at its Tampa sterile drug plant.
High risk -
DrugsReliance Life Sciences Private Limited
FDA warned India's Reliance Life Sciences over falsified microbiology records and aseptic failures in sterile drug production, prompting a recall.
High risk -
DrugsAuriga Research Pvt. Ltd.
Auriga Research, an Indian contract drug testing lab, failed to keep complete lab records and properly investigate failing test results.
High risk -
DevicesKoven Technologies, Inc.
FDA warns Koven Technologies that its Bidop 3 Doppler was labeled for fetal use without clearance and had quality system violations.
High risk -
DevicesLinemaster Switch Corporation
Linemaster Switch Corporation, a Connecticut maker of foot pedals for medical lasers, was cited for quality system failures after an FDA inspection.
High risk -
DevicesZIIP, Inc.
FDA warns ZIIP over quality-system violations and unapproved marketing of HALO 2.0, DOT, and gels.
High risk -
DrugsJubilant HollisterStier General Partnership
FDA found sterile drug manufacturing and investigation failures at Jubilant HollisterStier in Kirkland.
High risk -
DrugsPharmathen International S.A.
FDA warns Pharmathen over inadequate aseptic controls at its Greek plant making sterile drugs for the U.S.
High risk -
DevicesZOLL Medical Corporation
FDA warned ZOLL Medical after an inspection found quality-system, design-validation, supplier, and reporting failures for defibrillators, ventilators, and electrodes.
High risk -
DrugsAlchymars ICM SM Private Limited
FDA found Alchymars API manufacturing had poor equipment and facility maintenance, making its APIs adulterated and prompting an import alert.
High risk -
DrugsPar Health USA, LLC & Endo USA, Inc.
FDA cited Par Health USA/Endo USA’s Rochester plant for sterile injectable contamination-control, media fill, and visual inspection failures after an October 2025 inspection.
High risk -
DrugsMedical Products Laboratories, Inc.
Medical Products Laboratories was cited for manufacturing failures and selling unapproved prescription skin drugs.
High risk -
DrugsMicrobiological Testing & Consulting, LLC
FDA warned contract testing lab Microbiological Testing & Consulting over CGMP violations in drug product microbiological testing.
High risk -
DevicesPhysitemp Instruments, LLC
FDA says Physitemp sold clinical thermometers and temperature probes without FDA clearance and with unvalidated sterilization and welding.
High risk -
DevicesLonghorn Vaccines and Diagnostics LLC
Longhorn Vaccines and Diagnostics sold its PrimeStore MTM sample transport device without required quality controls or clearance for claims beyond its approved uses.
High risk -
DevicesDiasol, Inc.
Diasol sold unapproved citric acid hemodialysis disinfectants and had quality system violations, FDA says.
High risk -
DevicesMeridian Bioscience, Inc
FDA warns Meridian Bioscience's Magellan Diagnostics over quality system failures and unreported problems with its blood lead test kits.
High risk -
DevicesMAST Biosurgery USA, Inc.
MAST Biosurgery USA never ran promised endotoxin tests on its SurgiWrap FROST surgical mesh and failed to report patient injuries, FDA says.
High risk -
DrugsWinder Laboratories, LLC
FDA warns Winder Laboratories of adulterated prescription drugs due to cleaning and facility failures.
High risk -
DevicesRobbins Instruments, LLC
Medical Device/Misbranded/Unapproved Device/Quality System Regulation
-
DevicesDr. Joel Kaplan Inc.
Quality System Regulation for Medical Device Reporting/Adulterated/Misbranded
-
DevicesiRhythm Technologies, Inc.
Medical Devices/Adulterated/Quality System Regulation (QSR)